USPTO serial 77615699
LIFE TECHNOLOGIES
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 24, 2013
- Examiner
- ESTRADA, LINDA M
- Law office
- GENERIC WEB UPDATE
What this means
Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.
Need help with LIFE TECHNOLOGIES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
CARLSBAD, CA
Carlsbad, CA
Carlsbad, CA
Carlsbad, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kenya L. Williams
Kenya L. Williams Thermo Fisher Scientific5781 Van Allen WayCarlsbad, CA 92008United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Reagents and kits comprised of reagents for scientific or medical research use; diagnostic reagents and kits comprised of diagnostic reagents for scientific or medical research use; cellular pathway exploration tools, namely, ion channel assays, nuclear receptor assays, enzyme-linked immunosorbent assay (ELISA), kinase activity assays, and protein arrays all for scientific research purpose; reagents, namely, labeled or unlabeled recombinant proteins and antibodies for analysis and detection of one or more proteins and pathways for scientific research purposes; human, mouse and rat markers and antibodies conjugated to fluorescent chemical dyes; and human, mouse and rat markers and antibodies conjugated to proteins, namely, cytokines and chemokines, all for use in flow cytometry; culture media for non-medical use, culture growth supplements in the nature of biochemicals, reagents for use in cultures; reagents and buffers for use in analytical chemistry for use in cell and tissue cultures, transfection reagents, cryopreservation reagents, cell matrices, flow cytometry and flow cytometry reagents, antibiotics and cells in the nature of primary cells, stem cells and cell lines, all for use in scientific, laboratory, and medical research; in vitro ADME cell products, namely, fresh and cryopreserved hepatocytes and liver subcellular fractions, and transporters derived from a variety of species, including human, non-human primate, dog, rat and mouse for scientific research purposes; beads and microspheres, namely, magnetic particle-based biomedical separation systems comprising magnetizable polymer beads, the attached antibody and the magnetic particle concentrator for separating a specific selected cell population from a larger, more complex cell population; biological, chemical and biochemical preparations, namely, reagents and kits consisting of one or more of the following, namely, proteins, antibodies, nucleic acid arrays, protein arrays, nucleic acid molecules, protein ladders, nucleic acid ladders, peptides, kinases, growth factors, PCR fragments, cDNA libraries, vectors, enzymes, DNA polymerases, reverse transcriptases, molecules, clones, genes, cell, recombination proteins and sites, restriction enzymes, primers, nucleotides, plasmids, and reagents all for scientific medical research, or research use; microbiological culture media, animal blood sera, mammalian and insect cells, mammalian and insect cell culture media and cell culture reagents, all for scientific or medical research use; full line of scientific research kits consisting of one or more of the following -chemicals, antibodies, proteins, nucleic acids, hormones, purification supports, resins, cells, gels, probes, analytical chemistry buffers, and solutions for the expression, amplification, purification and analysis of biological samples; fluorescent chemicals and dyes for use in scientific research or medical research; electrophoresis gel and chromatography chemicals, analytical chemistry buffers, and solutions for scientific research or medical research; research and diagnostic biochemical, chemical and biological reagents, other than for medical or veterinary purposes, sold as kits for agricultural, ecological, DNA typing, food processing, forensic testing, environmental testing and research laboratories; reagents and assays used for detection and quantitation of DNA, RNA, protein or other analytes in solution, sold individually or in kits for medical research use; chemical reagents for non-medical purposes for the detection of pathogens and toxins in environmental samples; synthetic DNA primers for biotechnology use; synthetic DNA and molecules used as DNA molecular weight standards for use in the biotechnology field; nucleotide arrays for scientific use; biochemical reagents and analytical chemistry buffers all for scientific and medical research use, namely, reagents containing ligands, effector molecules and antibodies for scientific or medical research use; antibody-conjugated micro-beads and antibody-conjugated microspheres all for scientific and medical research use and for activation of immune system cells; fluorescent chemical dyes for clinical medical laboratory use; reagents for research purposes | ACTIVE | Jun 1, 2010 |
| 005 | Microbiological culture media, animal blood sera, mammalian and insect cells, mammalian and insect cell culture media and cell culture reagents, all for medical diagnostic use; diagnostic biochemical and biological reagents for use in detection or treatment for medical purposes; biological, chemical and biochemical preparations, namely, reagents and kits consisting of one or more of the following, including various combination thereof, proteins, antibodies, nucleic acid arrays, protein arrays, nucleic acid molecules, peptides, kinases, growth factors, PCR fragments, cDNA libraries, RNA, RNAi, vectors, enzymes, DNA polymerases, reverse transcriptases, molecules, clones, genes, cell, recombination proteins and sites, restriction enzymes, primers, plasmids, nucleotides, and reagents all for medical diagnostic use; medical diagnostic reagents and kits composed of medical diagnostic for the detection of pathogens and toxins in biological samples including veterinary samples; medical diagnostic biochemical, chemical and biological reagents and kits composed of medical diagnostic reagents for agricultural testing, ecological testing, DNA typing, food processing, forensic testing, and environmental testing; [ pharmaceuticals preparations and compositions for therapeutic use, namely, for expanding, selecting and deleting cells of the immune systems; ] preparations and compositions for therapeutic use, namely, for activating cells of the immune systems; [ pharmaceutical preparations for use in the treatment of cancer, infectious diseases and immunodeficiencies; ] antibody-conjugated beads, antibody-dye conjugates, antibodyconjugated micro-beads and antibody-conjugated microspheres for promoting a therapeutic effect on the body; chemical reagents for medical purposes | ACTIVE | Jun 1, 2010 |
| 009 | Computer software used for the collection, organization, analysis, integration and communication of scientific data; computer software used to operate laboratory instruments; laboratory instruments, namely, nucleic acid sequencers and synthesizers, protein sequencers, genetic analyzers, gel electrophoresis apparatus, electroporation apparatus, blot transfer apparatus, power supplies, filtration and separation apparatus, nucleic acid purification apparatus, nucleic acid quantitation apparatus, thermal cyclers, cytometers, flow cytometry apparatus, protein and peptide synthesizers, mass spectrometers and chromatographs, laboratory instruments for preparation of nucleic acid samples, laboratory robots; laboratory supplies, namely, racks, vials, caps, septa, needles, bottles, flasks, [ filters, ] tubes, and seals, plastic tray covers, micro plates, pipette tips, reagent reservoirs, optical heat field covers, plastic cards, and plastic capillary arrays; all for scientific and research use and diagnostics use; computer software for the construction of recombinant DNA molecules in the fields of molecular biology and genetics, building of functional or restriction maps, describing recombinant molecules, and obtaining the exact nucleotide sequences of recombinant DNA molecules; and computer software for use in database management in the fields of molecular biology and genetics that may be downloaded from a global computer network and computer software for use in database management in the fields of molecular biology and genetics; magnetic particle concentrator to be used with magnetic particlebased biomedical separations; full line of laboratory apparatus for protein and nucleic acid electrophoresis; [ optical filters for wavelengths of light; ] scientific equipment in the nature of detectors and analyzers of chemical and biological substances for non-medical purposes and component parts therefore; laboratory instrument for performing automated washing, dispensing, hybridization, and imaging of chip based sequence specific oligonucleotides; fluorometer and spectrophotometer used for detection and quantitation of DNA, RNA, protein or other analytes in solution, detachable power cord; [ detachable Universal Serial Bus (USB) data cord; scientific apparatus, namely, assay tubes; ] software for analysis or results, all for use with a fluorometer or spectrophotometer; laboratory instrument for the detection of pathogens and toxins in a sample; laboratory equipment, namely, apparatus in the nature of biochips for identification, detection of presence of biological or chemicals in a sample and determination of physical or chemical properties of a sample, synthesizers for making polymer arrays and parts therefor, and hybridization stations for making fluidic and microfluidic devices | ACTIVE | Jun 1, 2010 |
| 016 | [ Newsletters on products for scientific research ] | SECTION 8 - CANCELLED | Jan 1, 2009 |
| 037 | [ Installation, maintenance and repair of laboratory instruments for scientific, research, medical, and diagnostics use; Installation, maintenance and repair of computer hardware for scientific, research, medical, and diagnostics use ] | SECTION 8 - CANCELLED | Jan 1, 2009 |
| 042 | [ Providing an on-line computer database featuring information in the field of scientific and medical research; research in the fields of science, technology, medicine and health, namely, nucleic acid sequencing, analysis and synthesis of oligonucleotides and other molecules for others for use in life science research and biotechnology research; consultation services in the field of science and technology consultation in the field of nucleic acid sequencing, analysis and synthesis of oligonucleotides and other molecules for others for use in life science research and biotechnology research; computer services, namely, providing temporary use of on-line non-downloadable software for accessing and analyzing information in the field of science, technology, medicine, health and public policy; medical, research and laboratory diagnostic services in the field of nucleic acid sequencing, analysis and synthesis of oligonucleotides and other molecules for others for use in life science research and biotechnology research; product development for others; laboratory services, namely, nucleic acid sequencing, synthesis and analysis, analysis and synthesis of oligonucleotides and other molecules for others for use in life science research and biotechnology research; installation, maintenance and repair of computer software for scientific, research, medical, and diagnostic use; nucleic acid analysis; genetic research, namely, gene discovery; genetic disease research, genomics and gene expression research and development; pharmacokinetic research services; proteomics research services; gene identification, gene cloning, gene expression, gene mapping, electrophoresis, protein purification and analysis, and protein interaction detection all for scientific purposes; medical and scientific research; medical and scientific research for the development and commercialization of cell-based therapeutic immune system stimulators and enhancers to treat cancer and infectious diseases; technical research and consultation related thereto in the fields of pharmaceuticals, medicine, biological sciences, immunotherapy, and medical devices; development of new products in the fields of pharmaceuticals, medicine, biological sciences, immunotherapy, and medical devices for others; medical laboratory services; research and development for new immunotherapy products for others; biopharmaceutical research and development; scientific research services; medical laboratory testing and diagnostic services for others in the fields of science and research related thereto; scientific research, namely, developing customized microbiological, mammalian, and insect culture media, media formulations, and cell culture reagents, and evaluating culture media for others; contract laboratory services, namely, conducting drug-drug interaction studies, drug metabolism studies and hepatotoxicity studies, namely, enzyme induction and inhibition, reaction phenotyping, metabolite stability and profiling, and P-gp assays, and consulting services related thereto ] | SECTION 8 - CANCELLED | Jan 1, 2009 |
| 044 | [ Consultation in the field of medicine, health and pharmaceuticals ] | SECTION 8 - CANCELLED | Oct 1, 2012 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Life Technologies Corporation
- Other trademarks owned by Invitrogen Corporation
- Other trademarks owned by Invitrogen Corporation
- Other trademarks owned by Life Technologies Corporation
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 016
- Other trademarks in Class 037
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named LIFE TECHNOLOGIES
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 12, 2025 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Aug 12, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 12, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 12, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 12, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Aug 12, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Apr 27, 2024 | NA89 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | — |
| Apr 27, 2024 | RNL1 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active. |
| Apr 27, 2024 | 89AG | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | The USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary. |
| Apr 27, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jan 2, 2024 | E89R | TEAS SECTION 8 & 9 RECEIVED | — |
| Mar 10, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Mar 10, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 10, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 10, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 10, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Dec 24, 2022 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Nov 13, 2021 | A7OK | AMENDMENT UNDER SECTION 7 - PROCESSED | — |
| Nov 13, 2021 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jun 18, 2021 | ES7R | TEAS SECTION 7 REQUEST RECEIVED | — |
| Feb 19, 2020 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Feb 19, 2020 | C15P | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Feb 18, 2020 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Dec 18, 2019 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Dec 24, 2018 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jul 23, 2014 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 23, 2014 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 24, 2013 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 21, 2013 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Nov 20, 2013 | REGV | LAW OFFICE REGISTRATION REVIEW COMPLETED | — |
| Nov 20, 2013 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Oct 31, 2013 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 30, 2013 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Oct 30, 2013 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Oct 14, 2013 | IUAF | USE AMENDMENT FILED | — |
| Oct 14, 2013 | EXT5 | SOU EXTENSION 5 FILED | — |
| Oct 14, 2013 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 14, 2013 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jun 4, 2013 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 3, 2013 | EX4G | SOU EXTENSION 4 GRANTED | — |
| May 9, 2013 | EXT4 | SOU EXTENSION 4 FILED | — |
| May 9, 2013 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 26, 2012 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 25, 2012 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Oct 23, 2012 | EXT3 | SOU EXTENSION 3 FILED | — |
| Oct 23, 2012 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 18, 2012 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 17, 2012 | EX2G | SOU EXTENSION 2 GRANTED | — |
| May 9, 2012 | EXT2 | SOU EXTENSION 2 FILED | — |
| May 9, 2012 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 29, 2011 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 28, 2011 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Oct 27, 2011 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Oct 26, 2011 | EXT1 | SOU EXTENSION 1 FILED | — |
| Oct 26, 2011 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 2, 2011 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 2, 2011 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 10, 2011 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 25, 2011 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Feb 1, 2011 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 8, 2010 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Nov 9, 2010 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 9, 2010 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 3, 2010 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Oct 7, 2010 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Oct 7, 2010 | ALIE | ASSIGNED TO LIE | — |
| Sep 23, 2010 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 8, 2010 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 7, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 7, 2010 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 19, 2010 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 19, 2010 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 19, 2010 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 24, 2010 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 23, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 23, 2010 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 10, 2010 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 10, 2010 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 10, 2010 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 14, 2010 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 14, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 14, 2010 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 16, 2009 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 16, 2009 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 16, 2009 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 25, 2009 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 24, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 24, 2009 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 21, 2009 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 21, 2009 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 21, 2009 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 13, 2009 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 20, 2008 | NWAP | NEW APPLICATION ENTERED | — |